Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review to Assess Erenumab for Migraine Prevention; Guselkumab and Tildrakizumab for Plaque Psoriasis Internet Document : 9 Nov 2017. Available from: URL: https://icer-review.org/announcements/migraine-and-psoriasis-update/
Rights and permissions
About this article
Cite this article
ICER to review drugs for migraine prevention and plaque psoriasis. PharmacoEcon Outcomes News 791, 7 (2017). https://doi.org/10.1007/s40274-017-4491-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4491-9